West Bengal: SSKM hospital to perform double mastectomy surgery on 37-year-old female patient Medical Dialogues Team1 July 2022 8:45 AM GMTKolkata: For the first time ever in Bengal, a double mastectomy surgery will be performed on a patient admitted to government-run SSKM Hospital. The su...
DCGI nod to Biological E Corbevax as heterologous COVID booster Ruchika Sharma5 Jun 2022 6:30 AM GMTBE's CORBEVAX is the first such vaccine in India to be approved as a heterologous COVID-19 booster.
COVID vaccine for children: IAP expert comment Ananya Shrivastava7 May 2022 12:04 PM GMTIndian Academy of Paediatrics, twin cities branch, applauded the decision of the Drug Controller General of India (DCGI) which recently approved a...
DCGI panel asks Bharat Biotech to provide additional data on Covaxin for 2-12 years old Ruchika Sharma23 April 2022 9:19 AM GMTNo recommendations have been made as of now, sources told ANI.
Fourfold increase in investigational new drugs applications in India: DCGI Ruchika Sharma16 April 2022 5:56 AM GMTDr VG Somani said that the 'Made in India' drugs will make a difference and hit the world in the coming years.
Lupin launches Molnulup for COVID-19 treatment Medical Dialogues Bureau9 Jan 2022 6:30 AM GMTMumbai: Drugmaker Lupin on Friday said it has launched antiviral medication Molnupiravir under the brand name Molnulup in the country for the...
Can DCGI approved Molnupiravir bolster India's fight against COVID? Farhat Nasim3 Jan 2022 6:15 PM GMTNew Delhi: As countries prepare themselves to fight a possible 'next wave'. The new variant – Omicron has been making headline and a surge in Covid-19 ...
Health Bulletin 30/December/2021 Roshni Dhar30 Dec 2021 12:29 PM GMTHere are Top health stories of the dayNiti Aayog Releases Health Index NEET PG Impasse Continues, More Doctors Join Strike MBBS, BDS Admissions...
Cipla bags DCGI nod for COVID-19 oral antiviral, all set to launch Cipmolnu in India Ruchika Sharma28 Dec 2021 9:30 AM GMTMolnupiravir is an oral anti-viral that inhibits the replication of multiple RNA viruses including SARS-CoV-2.
161 seizures of COVID drugs, medical supplies made in black-marketing cases Ruchika Sharma1 Dec 2021 5:30 AM GMTNew Delhi: A total of 161 seizures of drugs and medical supplies like Remdesivir, Favipiravir and medical oxygen have been made by authorities in...
DCGI nod to phase III trials of Cadila Healthcare two-dose COVID vaccine Ruchika Sharma6 Oct 2021 10:35 AM GMTNew Delhi: Drug firm Cadila Healthcare on Tuesday said it has received permission from the Indian drug regulator for conducting phase III trials for...
Enzene Biosciences Romiplostim gets DCGI marketing authorization Ruchika Sharma20 Aug 2021 11:03 AM GMTRomiplostim, a therapeutic fusion protein, acts as a thrombopoieses stimulating factor, thereby restoring platelet levels and ameliorating the...
